Last Updated: September 24, 2026

Chiesi Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHIESI

CHIESI has fifteen approved drugs.

There are fifty-three US patents protecting CHIESI drugs.

Summary for Chiesi

US Patents:	53
Tradenames:	16
Ingredients:	10
NDAs:	15
Patent Litigation for Chiesi:	See patent lawsuits for Chiesi

Drugs and US Patents for Chiesi

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chiesi	CARDENE	nicardipine hydrochloride	INJECTABLE;INJECTION	019734-001	Jan 30, 1992	AP	RX	Yes	No		⤷ Start Trial				⤷ Start Trial
Chiesi	CARDENE	nicardipine hydrochloride	CAPSULE;ORAL	019488-002	Dec 21, 1988		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Chiesi	CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	019734-005	Nov 7, 2008		DISCN	Yes	No	7,612,102	⤷ Start Trial	Y			⤷ Start Trial
Chiesi	TRIMBOW	beclomethasone dipropionate; formoterol fumarate; glycopyrrolate	AEROSOL, METERED;INHALATION	219622-002	May 14, 2026		RX	Yes	Yes	10,617,638	⤷ Start Trial	Y			⤷ Start Trial
Chiesi	CLEVIPREX	clevidipine	EMULSION;INTRAVENOUS	022156-002	Aug 1, 2008		RX	Yes	Yes	11,103,490	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Chiesi

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chiesi	CLEVIPREX	clevidipine	EMULSION;INTRAVENOUS	022156-001	Aug 1, 2008	5,856,346	⤷ Start Trial
Chiesi	FERRIPROX	deferiprone	TABLET;ORAL	212269-001	May 19, 2020	7,049,328	⤷ Start Trial
Chiesi	CLEVIPREX	clevidipine	EMULSION;INTRAVENOUS	022156-002	Aug 1, 2008	5,856,346	⤷ Start Trial
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-002	Dec 21, 2012	6,492,365	⤷ Start Trial
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-004	Apr 23, 2015	9,265,758	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for CHIESI drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL	➤ Subscribe	2013-06-20
➤ Subscribe	Tablets	500 mg	➤ Subscribe	2016-01-29
➤ Subscribe	Injection	2.5 mg/mL, 10 mL Ampoules	➤ Subscribe	2006-12-27
➤ Subscribe	Inhalation Solution	300 mg/4 mL	➤ Subscribe	2017-08-31

International Patents for Chiesi Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Israel	220008	⤷ Start Trial
Hong Kong	1247818	⤷ Start Trial
Mexico	2023009676	⤷ Start Trial
Israel	276157	⤷ Start Trial
Cyprus	1117865	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Chiesi Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3089735	C03089735/01	Switzerland	⤷ Start Trial	PRODUCT NAME: GLYCOPYRRONIUMBROMID, FORMOTEROLFUMARAT-DIHYDRAT UND BECLOMETASONDIPROPIONAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67223 06.05.2020
1758555	93142	Luxembourg	⤷ Start Trial	PRODUCT NAME: BETULINE (EXTRAIT D'ECORCE DE BOULEAU) - EPISALVAN; FIRST REGISTRATION DATE: 20160118
0726894	1290008-0	Sweden	⤷ Start Trial	PRODUCT NAME: CLEVIDIPINE; NAT. REG. NO/DATE: 42321 20120120; FIRST REG.: GB PL 16881/0003 20111123
2515855	C201830006	Spain	⤷ Start Trial	PRODUCT NAME: COMBINACION DE BROMURO DE GLICOPIRRONIO, FORMOTEROL O UNA SAL DEL MISMO, Y DIPROPIONATO DE BECLOMETASONA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1208; DATE OF AUTHORISATION: 20170717; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1208; DATE OF FIRST AUTHORISATION IN EEA: 20170717
2515855	122018000007	Germany	⤷ Start Trial	PRODUCT NAME: KOMBINATION VON GLYCOPYRRONIUMBROMID, FORMOTEROL ODER EINEM SALZ DAVON UND BECLOMETASONDIPROPIONAT; REGISTRATION NO/DATE: EU/1/17/1208 20170717
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Chiesi

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.